RIGEL PHARMACEUTICALS INC — Director's Dealing 2017

Aug 24, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: RIGEL PHARMACEUTICALS INC (RIGL)
CIK: 0001034842
Period of Report: 2017-08-21

Reporting Person: Kotzin Brian L. (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2017-08-21	Stock Option (Right to Buy)	$2.2	A	80000	Acquired	2027-08-21	Common Stock (80000)	Direct

Footnotes

F1: The Option shall vest in equal monthly installments over the shorter of three years from the date of grant or the period beginning on the date the director is appointed to the Board and ending on the date of the annual meeting at which the director is first considered for election by the stockholders, provided that the non-employee director continues to provide services.